Clinical trials recruiting in Cheonan, South Korea

Phase breakdown

Conditions recruiting in Cheonan, South Korea

Recruiting trials in Cheonan, South Korea

• A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants
  NCT06246123 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Evaluate the Efficacy and Safety of CMG190303 in Patients With Type 2 Diabetes and Dyslipidemia
  NCT06772168 · Phase: Phase 3 · Ages: 19 Years to 80 Years · Sex: All (male and female)
• Neuclare Device for Temporary Improvement of Executive Function in Patients With Mild Cognitive Impairment and Prodromal Alzheimer's Disease
  NCT07239310 · Phase: Not applicable (e.g. observational or device study) · Ages: 55 Years to 90 Years · Sex: All (male and female)
• Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.
  NCT06858319 · Phase: Phase 3 · Ages: 18 Years to 100 Years · Sex: All (male and female)
• ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
  NCT07173751 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Cheonan, South Korea?

5 recruiting trials have at least one study site in Cheonan, South Korea.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.